| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $3.33B | +7.4% | +259.5% |
| R&D Expense | $53.0M | -7.0% | -66.0% |
| SG&A Expense | $105.0M | +1.9% | +36.4% |
| Operating Income | $1.32B | +27.2% | +598.4% |
| Pre-tax Income | $637.0M | +7.8% | +271.2% |
| Income Tax | $87.0M | -25.0% | +211.5% |
| Net Income | $550.0M |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $1.88B | -16.4% | — |
| Accounts Receivable | $633.0M | -5.9% | — |
| Inventory | $227.0M | +23.4% | — |
| Current Assets | $3.26B | -18.1% | — |
| Total Assets | $50.08B | +7.7% | — |
| Current Liabilities | $3.92B |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $4.46B | — | — |
| Capital Expenditures | $9.74B | — | — |
| Investing Cash Flow | -$9.58B | — | — |
| Financing Cash Flow | $4.05B | — | — |
| Free Cash Flow | -$5.29B | — | — |
| +15.8% |
| +287.1% |
| EPS (Basic) | $0.18 | +20.0% | +220.0% |
| EPS (Diluted) | $0.16 | +14.3% | +206.7% |
| +37.3% |
| — |
| Long-term Debt | $32.60B | +8.8% | — |
| Total Liabilities | $39.26B | +8.7% | — |
| Stockholders' Equity | $5.69B | +8.0% | — |